Revenue
Highest-ever quarterly revenue
Investor centre
Investor Centre.
Results, reports and disclosures.
Quarterly results, investor presentations, annual reports and statutory disclosures of Morepen Laboratories Limited.
Q1 FY27 performance
Recent performance.
At a glance.
EBITDA
Highest-ever quarterly EBITDA, 3x year on year
CDMO mandate
Entered commercial supplies
EBITDA margin
Blended EBITDA improves
Export growth
Prioritisation of customer mix
Medical Devices growth
Maintains strong growth
Investor presentations
The latest five.
Easy to scan.
Annual reports
Annual reporting.
Visual and direct.
Investor library
Everything else.
Compact and structured.
Important contacts
Investor & shareholder
contact directory.
Company Secretary
Vipul Kumar Srivastava
0124-4892000
investors@morepen.com
Investor Relations
Rajas Suri
rajas.suri@morepen.com
FD Related
Registrar & Share Transfer Agent
MAS Services Limited
T-34, 2nd Floor, Okhla Industrial Area,
Phase-II, New Delhi-110020
011-26387281/82/83
investor@masserv.com
demat@masserv.com
Nodal Officer for IEPF matters
Chief Financial OfficerAjay Kumar Sharma
2nd Floor, Tower C, DLF Cyber Park,
Udyog Vihar
Sector -20, Gurugram, Haryana - 122016
0124-4892000
corporate@morepen.com
Stay close to the published record.
Recent presentations and annual reports lead the experience; all other investor information remains clearly organised behind them.